Add Company
Join Now

XVIVO Revenue and Competitors

License our Company Data API

Gothenburg, Swe

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • XVIVO's estimated annual revenue is currently $27.3M per year.(i)
  • XVIVO's estimated revenue per employee is $155,000

Employee Data

  • XVIVO has 176 Employees.(i)
  • XVIVO grew their employee count by 21% last year.

XVIVO's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
Director Sales, Abdominal Transplantation, North AmericaReveal Email/Phone
4
Clinical Affairs Director EU/RoWReveal Email/Phone
5
Operations DirectorReveal Email/Phone
6
Global Marketing DirectorReveal Email/Phone
7
Director New Market DevelopmentReveal Email/Phone
8
Sales Director EuropeReveal Email/Phone
9
Marketing ManagerReveal Email/Phone
10
Technical Product ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$22.3M1445%N/AN/A
#2
$26.4M1704%N/AN/A
#3
$3.3M210%N/AN/A
#4
$4.8M317%N/AN/A
#5
$26.4M1704%N/AN/A
#6
$3.4M220%N/AN/A
#7
$18.1M11731%N/AN/A
#8
$13.6M88-5%N/AN/A
#9
$27.3M17621%N/AN/A
#10
$20M12930%N/AN/A
Add Company

What Is XVIVO?

The first global all organ company Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs – so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. We are committed to providing our customers with solutions and systems that can improve the transplant process outcome, facilitate the work for the transplant team, and enhance the long-term outcomes and quality of life of the transplant recipient. We believe nobody should die waiting for a new organ.

keywords:N/A

N/A

Total Funding

176

Number of Employees

$27.3M

Revenue (est)

21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$64.3M1773%N/A
#2
N/A18431%N/A
#3
$53.4M194-2%N/A
#4
$60.1M207-1%$30.9M
#5
$58.6M23926%$7.5M